Correlation Between Enanta Pharmaceuticals and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enanta Pharmaceuticals and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enanta Pharmaceuticals and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enanta Pharmaceuticals and ANI Pharmaceuticals, you can compare the effects of market volatilities on Enanta Pharmaceuticals and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enanta Pharmaceuticals with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enanta Pharmaceuticals and ANI Pharmaceuticals.
Diversification Opportunities for Enanta Pharmaceuticals and ANI Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Enanta and ANI is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Enanta Pharmaceuticals and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Enanta Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enanta Pharmaceuticals are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Enanta Pharmaceuticals i.e., Enanta Pharmaceuticals and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enanta Pharmaceuticals and ANI Pharmaceuticals
Given the investment horizon of 90 days Enanta Pharmaceuticals is expected to generate 6.62 times less return on investment than ANI Pharmaceuticals. In addition to that, Enanta Pharmaceuticals is 2.57 times more volatile than ANI Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. ANI Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 5,787 in ANI Pharmaceuticals on December 1, 2024 and sell it today you would earn a total of 402.00 from holding ANI Pharmaceuticals or generate 6.95% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Enanta Pharmaceuticals vs. ANI Pharmaceuticals
Performance |
Timeline |
Enanta Pharmaceuticals |
ANI Pharmaceuticals |
Enanta Pharmaceuticals and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enanta Pharmaceuticals and ANI Pharmaceuticals
The main advantage of trading using opposite Enanta Pharmaceuticals and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enanta Pharmaceuticals position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.Enanta Pharmaceuticals vs. Monte Rosa Therapeutics | Enanta Pharmaceuticals vs. Design Therapeutics | Enanta Pharmaceuticals vs. Werewolf Therapeutics | Enanta Pharmaceuticals vs. Ikena Oncology |
ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |